Drawing for PELTHOS THERAPEUTICS

USPTO serial 98424223

PELTHOS THERAPEUTICS

Reviewed by CopyMark Law Group

Status 732Notice of Allowance
Filing date
Status date
Registration date
—
Examiner
REGAN, JOHN B
Law office
INTENT TO USE SECTION

What this means

The USPTO has issued a Notice of Allowance. To complete registration you generally need to file a Statement of Use or an extension request before the deadline.

Status 732: Status 732 means the third six-month extension to file a Statement of Use was granted. You are past the midpoint of available extension time — plan SOU filing carefully.

Need help with PELTHOS THERAPEUTICS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Notice of Allowance, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,844*

Plus Government fees of $900

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Anthony P. DeRosa

Anthony P. DeRosa Myers Bigel, P.A.4130 Parklake Avenue, Suite 250Raleigh, NC 27612United States

Goods and services

ClassDescriptionStatusFirst use
005pharmaceutical preparations for use in dermatology and oncology, for the treatment of infectious diseases, namely viral, bacterial, and fungal diseases, for treating pre-cancerous conditions of the eye and skin, and for treating inflammationACTIVE—
010medical devices for use in the treating or diagnosing of dermatological conditions or diseases, of cancer or pre-cancerous conditions, of infections namely viral, bacterial, and fungal, of conditions of the eye and skin, and of inflammationACTIVE—
039distribution services, namely, delivery of pharmaceutical preparations and of medical devicesACTIVE—
040custom manufacture of pharmaceuticalsACTIVE—
042research and development in the fields of pharmaceutical products and of medical devicesACTIVE—
044medical servicesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 24, 2026EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Sep 24, 2026TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 24, 2026ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Sep 24, 2026REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Sep 24, 2026CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Sep 24, 2026COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jun 25, 2026EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Jun 25, 2026EX3GSOU EXTENSION 3 GRANTED—
Jun 24, 2026EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jun 23, 2026EXT3SOU EXTENSION 3 FILED—
Dec 31, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 31, 2025EX2GSOU EXTENSION 2 GRANTED—
Dec 30, 2025EXT2SOU EXTENSION 2 FILED—
Dec 30, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 11, 2025EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Dec 10, 2025EX1GSOU EXTENSION 1 GRANTED—
Dec 10, 2025AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 24, 2025EXT1SOU EXTENSION 1 FILED—
Jun 24, 2025EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 31, 2024NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Nov 19, 2024NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Nov 19, 2024PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2024NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 10, 2024CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Sep 18, 2024XAECEXAMINER'S AMENDMENT ENTERED—
Sep 18, 2024GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Sep 18, 2024GNEAEXAMINERS AMENDMENT E-MAILED—
Sep 18, 2024CNEAEXAMINERS AMENDMENT -WRITTEN—
Sep 16, 2024DOCKASSIGNED TO EXAMINER—
Jul 8, 2024NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Feb 28, 2024NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance